GURU.Markets stock price, segment price, and overall market index valuation
The company's share price PureTech Health plc
PureTech Health is a unique biotech company that creates and grows a portfolio of subsidiaries based on scientific discoveries. Its share price reflects both its success in R&D and the value of its stakes in companies it founded, such as Karuna Therapeutics.
Share prices of companies in the market segment - Holding
PureTech Health is a biotech company with a unique model: it creates and develops a portfolio of subsidiaries based on breakthrough medical discoveries. We've classified it as a "Holding" company. The chart below shows the overall performance of holding-structured companies in the healthcare sector, whose valuation depends on the success of their research.
Broad Market Index - GURU.Markets
PureTech Health is a biotech company with a unique model: it creates and grows a portfolio of subsidiaries based on breakthrough scientific discoveries. As a component of the GURU.Markets index, it represents the biotech innovation sector. The chart below represents the entire market. See how PureTech shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
PRTC - Daily change in the company's share price PureTech Health plc
The daily price change of PureTech Health, a biotech incubator, is a measure of its sensitivity to the performance of its portfolio projects. Change_co reflects complex volatility dependent on news from various fields of medicine. This metric is important for analyzing innovative holdings on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Holding
PureTech Health plc is a unique biotech holding. This chart highlights the sector's high volatility. Comparing it to PRTC, which creates subsidiaries for drug development, helps us appreciate its innovative yet risky business model.
Daily change in the price of a broad market stock, index - GURU.Markets
PureTech is a unique biotech company that creates and grows a portfolio of subsidiaries. Its diversified model aims to mitigate risks in the volatile biotech sector. The chart below reflects average fluctuations in this industry, providing context for evaluating PureTech shares.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization PureTech Health plc
PureTech Health plc's year-over-year performance tells the story of a unique model for creating and growing biotech companies. Its market capitalization growth over the past 12 months reflects not only the success of its own developments but also the progress of its portfolio of companies it founded (including the recently acquired Karuna Therapeutics), confirming the effectiveness of its scientific and business approach.
Annual dynamics of market capitalization of the market segment - Holding
PureTech Health plc is a unique biotech company that creates and grows a portfolio of multiple subsidiaries. This model diversifies risks. The chart shows how the market views its innovative approach to drug development and the success of its portfolio companies.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
PureTech is a unique biotech company that creates and develops a portfolio of several companies. Its stock performance is not a bet on a single drug, but on its team's ability to discover and commercialize breakthrough scientific ideas. The chart reflects the success of its entire ecosystem, which reduces risk compared to traditional biotech.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization PureTech Health plc
The performance of PureTech, a biotech holding company, depends on the success of its portfolio. The monthly fluctuations on the chart reflect not so much its own revenues as news about clinical trials and partnerships of its subsidiaries, as well as royalty income from approved drugs.
Monthly dynamics of market capitalization of the market segment - Holding
PureTech Health plc is a biotech company with a unique model that creates and develops new classes of drugs based on breakthrough scientific discoveries. The dynamics of its sector, shown in the chart, serve as background. It is interesting to assess how its ability to discover and advance cutting-edge scientific concepts, both internally and through its subsidiaries, creates value.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
PureTech Health is a biotech platform, not a single drug, which diversifies risk. Its performance is a composite of news from several portfolio companies. The chart shows how this approach smooths out volatility compared to individual biotechs and how it compares to the overall market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization PureTech Health plc
PureTech Health, a biotech holding company investing in breakthrough scientific research, exhibits complex dynamics. Its weekly stock price fluctuations reflect a cumulative response to news from its subsidiary portfolio companies, from clinical trial results to funding rounds, creating a unique risk profile.
Weekly dynamics of market capitalization of the market segment - Holding
Biotech holdings like PureTech Health represent a diversified bet on the sector. Their performance reflects the overall sentiment in biotech. The chart below shows this industry pulse. It allows you to compare how successful PureTech's unique model of creating and growing portfolio companies is compared to the average.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
PureTech Health is a biotech holding company that creates and develops a portfolio of scientific projects. Its shares are a bet on scientific breakthroughs, not economic cycles. The chart clearly shows how the company's weekly performance is detached from overall market trends and driven by news from its laboratories.
Market capitalization of the company, segment and market as a whole
PRTC - Market capitalization of the company PureTech Health plc
PureTech Health's market capitalization reflects investors' assessment of its unique model for creating and growing biotech companies. The chart shows the market's aggregate confidence in its portfolio of subsidiaries and their scientific platforms. Its dynamics reflect progress in clinical trials and the potential value of future drugs developed within its ecosystem.
PRTC - Share of the company's market capitalization PureTech Health plc within the market segment - Holding
PureTech Health occupies a unique position in the biotech sector. As a holding company, it doesn't create a single product, but rather manages a portfolio of innovative companies. Its share of the segment's market capitalization reflects not the success of a single drug, but rather investors' faith in its management's ability to select and develop promising scientific concepts to commercial success.
Market capitalization of the market segment - Holding
This chart shows the aggregate weight of the entire biotech sector, measured in hundreds of billions of dollars. For PureTech Health, which serves as an incubator for numerous innovative ideas, this line is an indicator of investors' overall risk appetite. A rising chart indicates an influx of capital into the industry, facilitating the financing and development of its portfolio companies.
Market capitalization of all companies included in a broad market index - GURU.Markets
PureTech Health develops medicines based on a new understanding of brain and immune biology. Its market value is not based on current sales, but rather on a scientific breakthrough. It represents the share of total capital that investors are willing to invest in a future revolution in medicine.
Book value capitalization of the company, segment and market as a whole
PRTC - Book value capitalization of the company PureTech Health plc
PureTech Health is a biotech incubator, and its book value is its scientific and financial arsenal. It consists of vast cash reserves for funding research and the value of its portfolio of established companies. How has this capital, which turns science into medicine, evolved? The chart below shows the history of its investments.
PRTC - Share of the company's book capitalization PureTech Health plc within the market segment - Holding
PureTech Health is a biotech incubator, and its value is backed by tangible assets. The company's balance sheet reflects the value of its cutting-edge laboratories and research centers, where breakthrough drugs are developed and tested. The chart shows the share of this physical R&D infrastructure in the innovative healthcare sector.
Market segment balance sheet capitalization - Holding
PureTech Health, as a biotech holding, has a lightweight model. The company doesn't own any laboratories, but invests in a portfolio of developments. The BCap_Seg chart for the biotech sector serves as a backdrop to its strategy—betting on scientific ideas rather than building its own infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
PureTech Health's capital is not a single plant, but a portfolio of investments in leading biotech companies and their research and development projects. Its book value reflects the combined potential of its subsidiary projects and patents. The chart shows how this "research" holding compares in terms of asset size to traditional pharmaceutical companies.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - PureTech Health plc
PureTech's balance sheet isn't its factories, but its capital and investments in its biotech portfolio. Its market valuation reflects its belief in its unique model for discovering and developing breakthrough scientific ideas. The chart shows the premium the market pays for this "think tank," not for its tangible assets.
Market to book capitalization ratio in a market segment - Holding
PureTech Health is a biotech company that creates and develops a portfolio of subsidiaries. Its valuation on this chart is not based on its tangible assets, but rather reflects investors' faith in its scientific platform and ability to discover and commercialize breakthrough medical technologies to solve serious problems.
Market to book capitalization ratio for the market as a whole
PureTech Health is a biotech holding company that creates and develops a portfolio of scientific companies. Its value lies in the potential of its subsidiaries and their intellectual property, not in their tangible assets. This chart helps assess the premium investors place on this innovative model and scientific prospects.
Debts of the company, segment and market as a whole
PRTC - Company debts PureTech Health plc
PureTech Health, with its unique model for creating and growing biotech companies, uses debt to finance its diverse portfolio. Debt capital allows it to advance several scientific programs simultaneously, from neuroscience to oncology. This chart shows how the holding manages financial leverage to maximize the chances of a major scientific breakthrough.
Market segment debts - Holding
PureTech Health operates under a unique model, creating and developing a portfolio of biotech companies. Its financial structure reflects the funding needs of numerous early-stage scientific projects. This chart shows the company's reliance on debt, which in biotech can be a sign of both asset maturity and increased risk.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio PureTech Health plc
PureTech Health is a biotech holding company investing in drug development. For such a company, debt fuels risky but potentially breakthrough research. This chart reflects the company's bet on the future success of its drugs. High values indicate high confidence or greater risks if clinical trials fail to meet expectations.
Market segment debt to market segment book capitalization - Holding
PureTech Health is a biotech holding company that creates and develops a portfolio of innovative medical companies. This model requires significant early-stage investment. The chart shows the collective debt burden in the biotech sector, providing context for assessing how PureTech and its competitors finance breakthrough research.
Debt to book value of all companies in the market
PureTech Health, a biopharmaceutical company, is at the forefront of science, where breakthrough research requires significant and long-term funding. This chart shows the debt-to-book value ratio of all companies in the market, helping to understand how aggressively PureTech uses debt capital for development compared to its overall market strategy.
P/E of the company, segment and market as a whole
P/E - PureTech Health plc
PureTech Health is a biotech company with a unique model: it creates and develops subsidiaries based on breakthrough scientific discoveries. This chart shows how the market values its innovation pipeline. The company's valuation depends not so much on current profits as on the success of its portfolio companies in clinical trials and their potential.
P/E of the market segment - Holding
PureTech Health operates under a unique model for building biotech companies. This chart shows the average valuation for the biotech sector as a whole. It helps investors understand the context: whether PureTech is valued as a typical industry player, or whether the market is pricing in a premium for its diversified portfolio and potential for multiple hits.
P/E of the market as a whole
PureTech Health is a biotech company that creates and develops a portfolio of subsidiaries based on cutting-edge science to treat serious diseases. This chart serves as a barometer of overall investor risk appetite. It helps understand whether PureTech's valuation reflects faith in its scientific pipeline or is part of a broader wave of optimism in biotech, which can be measured by benchmarking the company against the market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company PureTech Health plc
PureTech Health is a biotech holding that creates and develops companies based on breakthrough scientific discoveries. Its valuation on this chart depends on the expectations of future success of its portfolio companies, whether through the approval of a new drug or a partnership with a pharma giant. This reflects the market's faith in the scientific and commercial acumen of the PureTech team.
%20P%2FE%20PureTech%20Health%20plc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-PureTech-Health-plc&v=1772513446080 "Chart of the company's future (projected) P/E PureTech Health plc")
Future (projected) P/E of the market segment - Holding
PureTech Health is a biotech company with a unique model: it creates and develops a portfolio of several subsidiaries, each working on breakthrough drugs. The data presented compares the expected future profitability of this entire portfolio with forecasts for the biotech sector, reflecting the market's confidence in its scientific and commercial approach.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Holding&v=1772513446090 "Future (projected) P/E graph of the market segment - Holding")
Future (projected) P/E of the market as a whole
PureTech Health, which operates on a biotech company model, focuses on long-term scientific breakthroughs. This chart of overall market sentiment sets the backdrop against which investors evaluate its portfolio. During periods of optimism, the market is more willing to fund risky scientific research, which is essential to PureTech's future success.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513446097 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit PureTech Health plc
PureTech Health is more than just a biotech company; it's an innovator developing an entire ecosystem of breakthrough drugs. The chart below reflects its scientific ambitions and investments in the future of medicine. Every dip represents research expenditures that could lead to a blockbuster hit and a radical change in the financial picture.
Profit of companies in the market segment - Holding
PureTech Health is a biotech company developing a portfolio of breakthrough medical developments. Its business model is based on advancing innovative ideas from research to the clinic. Profitability in this sector is highly probabilistic: successes in clinical trials or partnerships with pharmaceutical giants can trigger rapid growth, reflecting the high-risk but potentially highly profitable nature of biotech innovation.
Overall market profit
PureTech Health is a biotech company with a unique business model. It not only develops its own drugs but also founds and funds startups based on promising scientific discoveries. This makes it a unique incubator for healthcare innovation. Its success reflects both scientific progress and its ability to commercialize it.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company PureTech Health plc
PureTech Health is a biotech holding company that creates and develops a portfolio of innovative medical companies. The chart below illustrates analysts' highly speculative expectations, as future profits depend on clinical trial success and commercialization of breakthrough drugs from the portfolio of companies it founded.
%20profit%20of%20the%20company%20PureTech%20Health%20plc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-PureTech-Health-plc&v=1772513446192 "Graph of future (projected) profit of the company PureTech Health plc")
Future (predicted) profit of companies in the market segment - Holding
PureTech Health is taking an unconventional approach, building a portfolio of breakthrough drugs targeting the connections between the brain, immune system, and gut. The revenue trend for the biopharmaceutical sector, reflected in this chart, reflects general expectations. For investors, this is an opportunity to evaluate how PureTech's unique scientific platform can outperform broader market trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Holding&v=1772513446216 "Graph of future (predicted) profits of companies in a market segment - Holding")
Future (predicted) profit of the market as a whole
PureTech Health is a biotech holding company that creates companies based on scientific discoveries. The success of such venture projects depends on the availability of capital, and investor sentiment is closely tied to the overall state of the economy. A positive outlook on this chart creates a favorable environment for raising funds for risky but promising startups.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513446227 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - PureTech Health plc
PureTech Health is a biotech company with a unique model: it creates and grows a portfolio of subsidiaries based on cutting-edge scientific discoveries. This chart shows how the market values its revenue, which can be irregular and consists of royalties and revenue from the companies it has created.
P/S market segment - Holding
PureTech Health is a biotech company developing and commercializing a portfolio of breakthrough drugs. Its model is based on developing scientific ideas to the clinical stage. This metric represents the average revenue estimate in the healthcare sector, allowing investors to understand how the market views the potential of PureTech's research portfolio.
P/S of the market as a whole
PureTech Health is a biotech company with a unique model. It doesn't just develop drugs, but also creates and finances a portfolio of subsidiaries based on promising scientific discoveries. This chart helps understand how the market values the revenue of such an innovative holding company compared to more traditional business models and the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company PureTech Health plc
PureTech Health operates under a unique model for creating and growing biotech companies. This chart reflects investor estimates of future revenues that could arise from successful clinical trials, partnerships, and royalties from its portfolio of subsidiaries. This is a bet on the company's scientific platform and ability to commercialize innovations.
%20P%2FS%20PureTech%20Health%20plc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-PureTech-Health-plc&v=1772513446290 "The graph of the company's future (projected) P/S PureTech Health plc")
Future (projected) P/S of the market segment - Holding
PureTech Health is a biotech company developing innovative medicines based on breakthrough scientific discoveries. The data presented compares its estimated future revenue potential with other holdings in the sector. The chart reflects investor confidence in the company's unique approach to development and the long-term success of its clinical pipeline.
%20P%2FS%20market%20segment%20graph%20-%20Holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Holding&v=1772513446294 "Future (projected) P/S market segment graph - Holding")
Future (projected) P/S of the market as a whole
PureTech Health is a biotech company with a unique model: it creates and grows a portfolio of subsidiaries based on cutting-edge scientific discoveries. Unlike the overall revenue dynamics shown in this chart, PureTech's value is determined by the scientific breakthroughs and successes of its portfolio companies, creating growth potential independent of macroeconomic conditions.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513446296 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales PureTech Health plc
This chart shows the revenue of PureTech Health, a unique biotech company. Its revenue is generated not from direct drug sales, but from the creation, financing, and subsequent monetization of an entire portfolio of subsidiaries developing breakthrough treatments. Revenue growth can be intermittent, reflecting successful deals, partnerships, or divestitures from its innovation incubator.
Sales of companies in the market segment - Holding
PureTech Health is a biotech company with a unique model. It doesn't develop drugs itself, but rather creates and funds subsidiaries that conduct breakthrough research. This chart shows the holding companies' revenues. It reflects the overall investment activity and the ability of entities like PureTech to successfully market and monetize their innovative projects.
Overall market sales
PureTech Health is a biotech company with a unique model: it creates and grows startups based on breakthrough scientific discoveries. While its success depends on clinical trial results, the overall economic climate, shown in this chart, influences the biotech investment climate. Growth in the chart facilitates capital raising for its portfolio companies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company PureTech Health plc
PureTech Health is a biotech company with a unique model: it creates and grows a portfolio of multiple subsidiaries. This revenue forecast chart aggregates analyst expectations for the success of the entire portfolio. Its growth is driven by forecasts for achieving clinical and regulatory milestones, which translates into royalty revenue and asset value growth.
%20sales%20of%20the%20company%20PureTech%20Health%20plc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-PureTech-Health-plc&v=1772513446401 "Schedule of future (projected) sales of the company PureTech Health plc")
Future (projected) sales of companies in the market segment - Holding
PureTech Health is a biotech company with a unique model. It doesn't just develop drugs; it creates and finances a portfolio of subsidiaries, each focused on a breakthrough scientific idea. This chart shows forecasts for the entire holding sector, allowing us to assess how favorable the overall conditions are for such innovative business models.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Holding&v=1772513446421 "Schedule of future (projected) sales of companies in the market segment - Holding")
Future (projected) sales of the market as a whole
PureTech Health is a biotechnology company developing a portfolio of innovative drugs. While demand for its drugs is driven by medical needs, the overall economic climate influences the investment climate. Positive market forecasts attract capital to the industry, enabling funding for long-term and expensive clinical trials.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513446431 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality PureTech Health plc
PureTech Health is not a traditional biopharmaceutical company, but a founder and investor in breakthrough medical startups. The dynamics in this chart reflect not operational performance, but rather the company's ability to monetize its portfolio through stake sales, technology licensing, or royalty payments, which makes its financial results highly uneven.
Market segment marginality - Holding
PureTech Health is a biotech company developing drugs based on an understanding of the Brain-Immune-Gut axis. This visualization allows us to evaluate its operational efficiency relative to the biotech sector. For a clinical-stage company, above-average profitability can be driven by successful partnerships and milestone payments for development.
Market marginality as a whole
PureTech Health is a biotech company with a unique model that founds and grows startups based on scientific discoveries. Its success is less dependent on general economic cycles, as shown in this chart. The key drivers are scientific breakthroughs and successful clinical trials by its subsidiaries, which create value independent of broader market conditions.
Employees in the company, segment and market as a whole
Number of employees in the company PureTech Health plc
PureTech Health is not a traditional biotech company, but an innovator. The team size reflected here reflects the size of the core scientific and management team. The company founds and develops new startups, so the total headcount may fluctuate dramatically as these portfolio companies are founded, grown, and subsequently spun off.
Share of the company's employees PureTech Health plc within the market segment - Holding
PureTech Health employs a unique model, building and financing a portfolio of biotech companies. Its own staff is small, but it manages a vast pool of scientific talent across its subsidiaries. This chart illustrates its strategy: a minimal number of direct employees conceals its colossal impact on the industry through intellectual capital management.
Number of employees in the market segment - Holding
PureTech Health operates under a unique model, creating and growing biotech companies based on cutting-edge scientific discoveries. This chart summarizes employment trends across the entire portfolio of innovative startups. It illustrates how scientific breakthroughs translate into new jobs for scientists and researchers, reflecting the overall progress of the portfolio and its transition to clinical stages.
Number of employees in the market as a whole
PureTech Health operates as a biotech incubator, creating and funding a portfolio of independent companies. Its workforce dynamics don't reflect hiring at a single company, but rather the pulse of the entire ecosystem. This chart allows you to assess how PureTech's strategy for launching and developing new projects correlates with the overall employment situation in high-tech and knowledge-intensive industries.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company PureTech Health plc (PRTC)
PureTech Health isn't a traditional company, but a biotech holding company that creates and finances a portfolio of startups. Its own staff is small, but value is created in its subsidiaries. This chart shows how the market values this model: market capitalization is divided by the minimum number of employees, reflecting the value of its innovation portfolio rather than its operating activities.
%20of%20the%20company%20PureTech%20Health%20plc%20(PRTC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-PureTech-Health-plc-PRTC&v=1772513446575 "Chart of market capitalization per employee (in thousands of dollars) of the company PureTech Health plc (PRTC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Holding
PureTech Health is a biopharmaceutical holding company that creates and develops a portfolio of innovative medical companies. This metric allows investors to assess how effectively the management team generates market value. Deviation from the industry average may indicate the uniqueness of their business model and the value of the assets they create.
%20by%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Holding&v=1772513446583 "Market capitalization per employee (in thousands of dollars) by market segment - Holding")
Market capitalization per employee (in thousands of dollars) for the overall market
PureTech Health operates as a biotech hub, creating and funding a portfolio of independent companies. This reflects a unique approach: a small, central team manages intellectual property and scientific breakthroughs worth hundreds of millions. The value lies in the portfolio's potential, not in its operational staff.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513446597 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company PureTech Health plc (PRTC)
PureTech Health isn't a traditional pharma company, but a biotech incubator. Their business is to discover, finance, and develop breakthrough scientific ideas. This chart demonstrates the effectiveness of their "light" model. Revenue is generated not by an army of salespeople, but by a small team of scientists and managers who bring assets to the sale or partnership stage, generating high intellectual property value.
%20Chart%20PureTech%20Health%20plc%20(PRTC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-PureTech-Health-plc-PRTC&v=1772513446602 "Company Profit Per Employee (in thousands of dollars) Chart PureTech Health plc (PRTC)")
Profit per employee (in thousands of dollars) in the market segment - Holding
PureTech Health is an atypical biotech company; they create and grow a portfolio of several subsidiaries. Their "profit" often depends on the success of these portfolio companies. This metric reflects the effectiveness of their central management team: how capable a small team is of generating high value (through partnerships or asset sales) compared to the industry.
%20in%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Holding&v=1772513446622 "Chart of profit per employee (in thousands of dollars) in the market segment - Holding")
Profit per employee (in thousands of dollars) for the market as a whole
PureTech Health is an atypical biotech holding company. It creates and finances a portfolio of breakthrough medical startups. Its profitability per employee reflects not operational performance, but rather the effectiveness of a small team in managing large R&D assets, bringing them to market, or selling them. This is a performance metric for an innovation incubator.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513446634 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee PureTech Health plc (PRTC)
PureTech Health is a biotech company operating under a unique model of creating and growing spin-off startups. This chart shows how their scientific discoveries and investments in portfolio companies are beginning to translate into revenue. This metric reflects progress from research to commercialization.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-PureTech-Health-plc-PRTC&v=1772513446641 "Sales chart per company employee PureTech Health plc (PRTC)")
Sales per employee in the market segment - Holding
PureTech Health (PRTC) is an atypical biotech company operating under the hub model. They are building a portfolio of subsidiaries that advance breakthrough R&D. This chart shows the revenue (from royalties, partnerships, and sales) per employee. This allows us to assess the productivity of their R&D incubator model and how effectively their "think tank" generates revenue compared to other biotech holdings.
Sales per employee for the market as a whole
PureTech Health operates using a unique "hub-and-spoke" model. They don't simply develop drugs; they create and fund separate companies around promising scientific discoveries. This metric reflects the effectiveness of their R&D platform. It shows how a small, central team generates revenue (through royalties and partnerships) from the success of its portfolio.
Short shares by company, segment and market as a whole
Shares shorted by company PureTech Health plc (PRTC)
PureTech Health is a biotech company developing a portfolio of innovative drugs. This chart reflects the volume of bearish bets. Shorting biotech often means betting on failure. Bears may doubt the success of its clinical trials or expect the company to require new financing, which would dilute shareholders' stakes.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-PureTech-Health-plc-PRTC&v=1772513446687 "Short Shares Chart for the Company PureTech Health plc (PRTC)")
Shares shorted by market segment - Holding
PureTech Health is a biotech company that develops and markets new classes of drugs. Their business is science and clinical trials. This metric reflects market skepticism. A rise in shorts indicates that investors are betting on the failure of their key drugs in the pipeline or lack confidence in their business model.
Shares shorted by the overall market
PureTech Health (PRTC) is a biotech holding that develops and commercializes new drugs through its subsidiaries. Its value is determined by the valuation of its portfolio of startups. This chart demonstrates risk aversion. When fears rise, investors undervalue complex portfolio plays, preferring direct bets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator PureTech Health plc (PRTC)
PureTech Health is a biotech holding company that creates and develops companies based on its platform. Its valuation depends on the portfolio's success. A chart above 70 may reflect positive news from portfolio companies or new investments. A level below 30 is associated with R&D setbacks or a general decline in biotech.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-PureTech-Health-plc-PRTC&v=1772513446771 "RSI 14 indicator chart for the company's stock PureTech Health plc (PRTC)")
RSI 14 Market Segment - Holding
PureTech (PRTC) is a biotech incubator. They don't just dig one trench, but *create* and *finance* a portfolio of subsidiaries (like Karuna and VEDA) based on breakthrough science. The RSI_14_Seg for "Holding" (biotech) shows the overall sentiment. It helps us understand: is PRTC's growth a reflection of their portfolio or a general overheating?
RSI 14 for the overall market
PureTech (PRTC) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PRTC (PureTech Health plc)
PureTech Health (PRTC) is a biotech holding company that develops proprietary drugs (based on the brain and immune system) and holds stakes in other companies. This chart shows the average target price. It reflects analysts' assessments of the value of both the company's internal portfolio and external assets.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PRTC-PureTech-Health-plc&v=1772513446801 "A chart showing analyst consensus forecasts for the expected stock price. PRTC (PureTech Health plc)")
The difference between the consensus estimate and the actual stock price PRTC (PureTech Health plc)
PureTech (PRTC) is a unique biotech holding. The company doesn't focus on a single drug, but rather creates and develops a portfolio of biotech startups based on breakthrough science (including royalties from KarXT). This chart shows the difference between the consensus forecast and the price, reflecting analysts' confidence in this R&D model.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PRTC-PureTech-Health-plc&v=1772513446832 "A chart showing the difference between the consensus forecast and the actual stock price. PRTC (PureTech Health plc)")
Analyst consensus forecast for stock prices by market segment - Holding
PureTech Health is a biotech incubator. The company doesn't develop drugs itself, but rather establishes and finances subsidiaries (including Karuna), which it then takes public or sells. This chart shows analysts' general expectations for the holding company sector, reflecting whether experts believe in this venture-based R&D model.
Analysts' consensus forecast for the overall market share price
PureTech Health is a biotech incubator. They don't develop a single drug, but rather create and fund a portfolio of R&D companies based on breakthrough ideas. This chart shows overall market sentiment. For PureTech, whose business is "venture biotech," it's important to understand how risk appetite (sentiment) influences their portfolio valuation and their ability to take companies public. (349)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index PureTech Health plc
PureTech is a biotech incubator. They don't just develop drugs; they create companies around breakthrough scientific ideas (their Founded Entities, like Karuna) and license their technologies. This chart is a barometer of their NAV. It likely reflects their net asset value, which consists of their stakes in the companies they founded and their own R&D pipeline.
AKIMA Market Segment Index - Holding
PureTech (PRTC) is a unique biotech holding company; unlike R&D, the company operates as an incubator – it creates, finances, and commercializes a portfolio of independent biotech companies (including Karuna, VOR). This summary metric evaluates R&D. The graph shows the average value for the segment. This benchmark: how does this unique holding model (PRTC) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
PureTech Health is a biopharmaceutical company developing new drugs (Hub-and-Spoke model). It develops its own programs and establishes new companies. This chart, reflecting the market average, provides a macro backdrop. It helps assess how this innovative incubator and developer compares to overall economic trends.
